Cytotoxicity of dolastatin 10 dolastatin 15 and dolastatin k333 human tumor xenografts in vitro
Winterhalter, B.R.; Berger, D.P.; Pettit, G.R.; Fiebig, H.H.
Proceedings of the American Association for Cancer Research Annual Meeting 32: 402
1991
ISSN/ISBN: 0569-2261
Accession: 030788609
PDF emailed within 1 workday: $29.90
Related References
Pettit, G.R.; Xu, J.P.ng 2001: Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 Official Gazette of the United States Patent and Trademark Office Patents 1246(5)Quentmeier, H.; Brauer, S.; Pettit, G.R.; Drexler, H.G. 1992: Cytostatic effects of dolastatin 10 and dolastatin 15 on human leukemia cell lines Leukemia and Lymphoma 6(3): 245-250
Steube, K.G.; Grunicke, D.; Pietsch, T.; Gignac, S.M.; Pettit, G.R.; Drexler, H.G. 1992: Dolastatin 10 and dolastatin 15: effects of two natural peptides on growth and differentiation of leukemia cells Leukemia 6(10): 1048-1053
Alcaro, S.; Marino, T.; Ortuso, F.; Russo, N. 2006: Conformational behavior of antineoplastic peptides Dolastatin 10 and Dolastatin 15 from Monte Carlo and molecular dynamics simulations International Journal of Quantum Chemistry 107(2): 318-325
Poncet, J.; Busquet, M.; Roux, F.; Pierré, A.; Atassi, G.; Jouin, P. 1998: Synthesis and biological activity of chimeric structures derived from the cytotoxic natural compounds dolastatin 10 and dolastatin 15 Journal of Medicinal Chemistry 41(9): 1524-1530
Steube, K.G.; Quentmeier, H.; Pettit, G.R.; Pietsch, T.; Brauer, S.; Grunicke, D.; Gignac, S.M.; Drexler, H.G. 1992: Inhibition of cellular proliferation by the natural peptides dolastatin 10 and dolastatin 15 Abraham, N G, Konwalinka, G, Marks, P, Sachs, L, Tavassoli, M Molecular biology of haematopoiesis, Vol 2: 567-573
Galéotti, N.; Poncet, J.; Jouin, P. 2002: Post-Source Decay Analysis of Dolastatin 10 and Dolastatin 15 by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry European Journal of Mass Spectrometry 8(4): 311-321
Fujita, F.; Koike, M.; Fujita, M.; Sakamoto, Y.; Tsukagoshi, S. 2000: Antitumor effects of TZT-1027, a novel dolastatin 10 derivative, on human tumor xenografts in nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(3): 451-458
Roux, F.; Maugras, I.; Poncet, J.; Niel, G.; Jouin, P. 1994: Synthesis of dolastatin 10 and -dolastatin 10 Tetrahedron 50(18): 5345-5360
Roux, F.; Galeotti, N.; Poncet, J.; Jouin, P.; Cros, S.; Zenke, G. 1994: Synthesis and in vitro cytotoxicity of diastereoisomerically modified dolastatin 15 analogues Bioorganic and Medicinal Chemistry Letters 4(16): 1947-1950
Nicoletti, M.I.; Turatto, M.; Martinelli, M.; Barlozzari, T.; Giavazzi, R. 2000: Oral antitumor activity of a Dolastatin 15 analog, LU223651, against human ovarian carcinoma xenografts Proceedings of the American Association for Cancer Research Annual Meeting 41: 303
Villalona Calero, M.; Degen, D.; Barlozzari, T.; Von Hoff, D. 1995: LU103793 Evaluation by human tumor clonogenic assay of a novel dolastatin Proceedings of the American Association for Cancer Research Annual Meeting 36: 394
May, R.D.; MurphyM.J.Jr.; Erickson Miller, C.L.; Tomaszewski, J.E.; Osborn, B.L.; Page, J.G. 1994: Myelotoxicity evaluation of Dolastatin 10 and Swainsonine using murine, canine, and human in vitro CFU-GM assays Proceedings of the American Association for Cancer Research Annual Meeting 35: 402
Subramanian, P.K.; Tseng, C.C.; Vishnuvajjala, R. 1997: Synthesis and cytotoxicity of androstanyl ureas as dolastatin 10 model candidates Abstracts of Papers American Chemical Society 213(1-3): MEDI 210
Bai, R.; Edler, M.C.; Bonate, P.L.; Copeland, T.D.; Pettit, G.R.; Ludueña, R.F.; Hamel, E. 2009: Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity Molecular Pharmacology 75(1): 218-226
Verdier Pinard, P.; Bai, R.; Hamel, E. 1998: Uptake of dolastatin 10 and vinblastine by tumor cells Proceedings of the American Association for Cancer Research Annual Meeting 39: 165
Bai, R.; Roach, M.C.; Jayaram, S.K.; Barkoczy, J.; Pettit, G.R.; Ludueña, R.F.; Hamel, E. 1993: Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity Biochemical Pharmacology 45(7): 1503-1515
Smith, P.; Nelson, C.; Janssen, B.; Haupt, A.; Barlozzari, T. 1995: Pre-clinical anti-tumor activity of a novel water-soluble Dolastatin 15 analog Proceedings of the American Association for Cancer Research Annual Meeting 36: 393
Woyke, T.; Pettit, G.R.; Winkelmann, G.; Pettit, R.K. 2001: In vitro activities and postantifungal effects of the potent dolastatin 10 derivative auristatin PHE Antimicrobial Agents and ChemoTherapy 45(12): 3580-3584
Aheme, W.; Hardcastle, A.; Valenti, M.; Bryant, A.; Rogers, P.; Srirangam, J.K.; Petit, G.R.; Kelland, L.R. 1995: In vitro and in vivo antitumour evaluation of dolastatin 10 and 15 and their measurement in plasma by radioimmunoassay Proceedings of the American Association for Cancer Research Annual Meeting 36: 385